News | February 24, 2026
biomodal expands multiomic reach with Element Biosciences pact
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
The decision follows compelling data from the AMPLIFY Phase III trial, demonstrating that 77% of patients receiving the Calquence-venetoclax combination were progression-free at three years
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
Iberdomide has the potential to be the first approved CELMoD agent
MYC, a master regulator of oncogenic transcription, drives multiple high-burden cancers but has long eluded direct pharmacologic control
Under the deal, Uniphar will serve as LYMPHIR’s exclusive distribution partner across designated Western and Eastern European territories
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
HCG clinicians contributing to one of the largest bodies of oncology research from India
Leading the showcase is FCT iStream, Fujifilm’s latest CT scanner built on a “Less is More” design philosophy
Subscribe To Our Newsletter & Stay Updated
